Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

The Global Car T-cell Therapy Market is forescasted to grow at a CAGR of 63.15% during the period 2018-2022

ReportBuyer
Posted on: 10 Oct 18
The Global Car T-cell Therapy Market is forescasted to grow at a CAGR of 63.15% during the period 2018-2022

PR Newswire

LONDON, Oct. 9, 2018

LONDON, Oct. 9, 2018 /PRNewswire/ -- About CAR T-cell Therapy

Chimeric antigen receptor (CAR) is one of the recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology. CARs are engineered receptors to attack cancer cells. In this therapy, patients' T-cells are modified to attack cancer cells. In this therapy, patients' T-cells are modified in the laboratory to fight against various cancer indications.

Download the full report: https://www.reportbuyer.com/product/5583968

Technavio's analysts forecast the Global CAR T-cell Therapy Market to grow at a CAGR of 63.15% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the CAR T-cell therapy market. To calculate the market size, the report considers the revenue generated from the application of CAR T-cell therapy across the globe.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, CAR T-cell therapy market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• bluebird bio
• CARsgen Therapeutics
• Celgene
• Gilead
• Novartis

Market driver
• Proven effectiveness of CAR T-cell therapy
• For a full, detailed list, view our report

Market challenge
• High cost of CAR T-cell therapy
• For a full, detailed list, view our report

Market trend
• Collaborative R&D efforts
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Download the full report: https://www.reportbuyer.com/product/5583968

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

View original content:http://www.prnewswire.com/news-releases/the-global-car-t-cell-therapy-market-is-forescasted-to-grow-at-a-cagr-of-63-15-during-the-period-2018-2022--300727771.html

SOURCE ReportBuyer

PR Newswire
www.prnewswire.com

Last updated on: 10/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.